「肝胆膵消化器病学」は横浜市立大学附属病院の消化器内科部門です


  1. Arimoto J, Higurashi T, Kato S, Goto S, Suzuki S, Nakajima A, Atsukawa K.Cardiac tumors and gastroendoscopy: endoscopic resection of left ventricular tumors.Endoscopy. 2017 Feb;49(S 01):E23-E24. doi: 10.1055/s-0042-122139. No abstract available
  2. Honda Y, Kessoku T, Ogawa Y, Tomeno W, Imajo K, Fujita K, Yoneda M, Takizawa T, Saito S, Nagashima Y, Nakajima A：Pemafibrate, a novel selective peroxisome proliferator-activated receptor alpha modulator, improves the pathogenesis in a rodent model of nonalcoholic steatohepatitis.Sci Rep. 2017 Feb 14;7:42477. doi: 10.1038/srep42477.
  3. Yamada E, Watanabe S, Nakajima A. Associations of Mental Health and Physical Function with Colonoscopy-related Pain. Intern Med. 2017;56(4):383-388. doi:10.2169/internalmedicine.56.7465. PubMed PMID: 28202858.
  4. Hotta K, Kikuchi M, Kitamoto T, Kitamoto A, Ogawa Y, Honda Y, Kessoku T, Kobayashi K, Yoneda M, Imajo K, Tomeno W, Nakaya A, Suzuki Y, Saito S, Nakajima A. Identification of core gene networks and hub genes associated with progression of nonalcoholic fatty liver disease by RNA sequencing. Hepatol Res. 2017 Feb 20. doi: 10.1111/hepr.12877. [Epub ahead of print] PubMed PMID: 28219123.
  5. Sakai E, Higurashi T, Ohkubo H, Hosono K, Ueda A, Matsuhashi N, Nakajima A: Investigation of Small Bowel Abnormalities in HIV-Infected Patients Using Capsule Endoscopy. Gastroenterol Res Pract, Epub 2017 Mar 20.
  6. Kato T, Honda Y, Kurita Y, Iwasaki A, Sato T, Kessoku T, Uchiyama S, Ogawa Y, Ohkubo H, Higurashi T, Yamanaka T, Usuda H, Wada K, Nakajima A: Lubiprostone improves intestinal permeability in humans, a novel therapy for the leaky gut: A prospective randomized pilot study in healthy volunteers. PLoS One, 2017 Apr 14;12(4):e0175626.
  7. Fujii T, Sakai E, Takahashi H , Yamada E, Ohkubo H, Higurashi T, Nakajima A: The distribution of human rectal aberrant crypt foci and criteria for defining the counting area. Oncology Letters. 13: 4501-4504, 2017. Received July 4, 2016; Accepted March 29, 2017 DOI: 10.3892/ol.2017.6003
  8. Yamada E, Kuriyama H, Uchida E, Murata Y, Hata Y, Tagri M, Isozaki Y, Oyamada H, Ozawa Y, Ito T, Mizuki A, Inamori M, Manabe N, Haruma K, Nakajima A : Association between endoscopic findings related to colonic diverticula and bowel habits: a multicenter study in Japan. J Gastroenterol Hepatol. 2017 Apr 19. doi: 10.1111/jgh.13805. [Epub ahead of print] PubMed PMID: 28425144.
  9. Hasegawa S, Kobayashi N, Tokuhisa M, Goto A, Takano S, Takada Y, Kaneta T,Mori R, Matsuyama R, Endo I, Yamanaka S, Nakajima A, Inoue T, Ichikawa Y.Clinical Usefulness of Somatostatin Receptor Scintigraphy in Japanese Patients with Gastroenteropancreatic Neuroendocrine Tumors. Digestion. 2017 Jun 14;96(1):13-20. doi: 10.1159/000470838.
  10. Ohkubo H, Fuyuki A, Arimoto J, Higurashi T, Nonaka T, Inoh Y, Iida H, Inamori M, Kaneda T, Nakajima A. Efficacy of percutaneous endoscopic gastro-jejunostomy　(PEG-J) decompression therapy for patients with chronic intestinal pseudo-obstruction (CIPO). Neurogastroenterol Motil. 2017 Jun 20. doi:10.1111/nmo.13127. [Epub ahead of print] PubMed PMID: 28631871.
  11. Umezawa S, Higurashi T, Nakajima A: AMPK: therapeutic target for diabetes and cancer prevention. Curr Pharm Des. 2017 Jul 13. doi: 10.2174/ 0929867324666170713150440. [Epub ahead of print] PubMed PMID: 28714409.
  12. Niikura R, Yamada A, Maki K, Nakamura M, Watabe H, Fujishiro M, Oka S, Esaki　M, Fujimori S, Nakajima A, Ohmiya N, Matsumoto T, Tanaka S, Koike K, Sakamoto C. Associations between drugs and small-bowel mucosal bleeding: A multicenter capsule-endoscopy study. Dig Endosc. 2017 Jul 18. doi: 10.1111/den.12922. [Epub ahead of print] PubMed PMID: 28719079.
  13. Chiba H, Tachikawa J, Kurihara D, Ashikari K, Takahashi A, Kuwabara H, Nakaoka M, Morohashi T, Goto T, Ohata K, Nakajima A. Successful endoscopic submucosal dissection of colon cancer with severe fibrosis after tattooing. Clin J Gastroenterol. 2017 Aug 7. doi: 10.1007/s12328-017-0770-z. [Epub ahead of print] PubMed PMID: 28785991.
  14. Honda Y, Kessoku T, Sumida Y, Kobayashi T, Kato T, Ogawa Y, Tomeno W, Imajo K,Fujita K, Yoneda M, Kataoka K, Taguri M, Yamanaka T, Seko Y, Tanaka S, Saito S, Ono M, Oeda S, Eguchi Y, Aoi W, Sato K, Itoh Y, Nakajima A. Efficacy of glutathione for the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, multicenter, pilot study. BMC Gastroenterol. 2017 Aug 8;17(1):96. doi: 10.1186/s12876-017-0652-3. PubMed PMID: 28789631.
  15. Nakajima A, Seki M, Taniguchi S. Determining an optimal clinical dose of elobixibat, a novel inhibitor of the ileal bile acid transporter, in Japanese patients with chronic constipation: a phase II, multicenter, double-blind, placebo-controlled randomized clinical trial. J Gastroenterol. 2017 Aug 24. doi: 10.1007/s00535-017-1383-5. [Epub ahead of print] PubMed PMID: 28840422.
  16. Oeda S, Takahashi H, Yoshida H, Ogawa Y, Imajo K, Yoneda M, Koshiyama Y, Ono M, Hyogo H, Kawaguchi T, Fujii H, Nishino K, Sumida Y, Tanaka S, Kawanaka M, Torimura T, Saibara T, Kawaguchi A, Nakajima A, Eguchi Y; Japan Study Group for NAFLD (JSG-NAFLD)：Prevalence of pruritus in patients with chronic liver disease:a multicenter study. Hepatol Res. 2017 Sep 6. doi: 10.1111/hepr.12978. [Epub　ahead of print] PubMed PMID: 28877392.
  17. Yamada E, Namiki Y, Takano Y, Takamine H, Inazumi K, Sasaki H, Yamada M, Ito S, Iwasaki T, Mantani N, Minami T, Osada UN, Terauchi Y, Nakajima A：Clinical factors associated with the symptoms of constipation in patients with diabetes mellitus: a multicenter study. J Gastroenterol Hepatol. 2017 Oct 19. doi: 10.1111/jgh.14022.
  18. Hotta K, Kitamoto T, Kitamoto A, Ogawa Y, Honda Y, Kessoku T, Yoneda M, Imajo K, Tomeno W, Saito S, Nakajima A： Identification of the genomic region under epigenetic regulation during nonalcoholic fatty liver disease progression. Hepatol Res. 2017 Oct 23. doi: 10.1111/hepr.12992.
  19. Uchiyama T, Higurashi T, Kuriyama H, Kondo Y, Hata Y, Nakajima A. Oral esomeprazole vs injectable omeprazole for the prevention of hemorrhage after endoscopic submucosal dissection. World J Gastrointest Endosc. 2017 Oct 16;9(10):514-520. doi: 10.4253/wjge.v9.i10.514. PubMed PMID: 29085562; PubMed Central PMCID: PMC5648994.
  20. Yoneda M, Imajo K, Takahashi H, Ogawa Y, Eguchi Y, Sumida Y, Yoneda M, Kawanaka M, Saito S, Tokushige K, Nakajima A. Clinical strategy of diagnosing and following patients with nonalcoholic fatty liver disease based on invasive and noninvasive methods. J Gastroenterol. 2017 Nov 24. doi: 10.1007/s00535-017-1414-2. [Epub ahead of print] Review. PubMed PMID: 29177681.
  21. Arimoto J, Higurashi T, Chiba H, Misawa N, Yoshihara T, Kato T, Kanoshima K, Fuyuki A, Ohkubo H, Goto S, Ishikawa Y, Tachikawa J, Ashikari K, Nonaka T, Taguri M, Kuriyama H, Atsukawa K, Nakajima A. Continued Use of a Single Antiplatelet Agent Does Not Increase the Risk of Delayed Bleeding After Colorectal Endoscopic Submucosal Dissection. Dig Dis Sci. 2017 Nov 24. doi: 10.1007/s10620-017-4843-0. [Epub ahead of print] PubMed PMID: 29177848.
  22. Fukudo S, Nakajima A, Fujiyama Y, Kosako M, Nakagawa A, Akiho H, Nakashima Y, Johnston JM, Miwa H. Determining an optimal dose of linaclotide for use in Japanese patients with irritable bowel syndrome with constipation: A phase II randomized, double-blind, placebo-controlled study. Neurogastroenterol Motil. 2017 Dec 26. doi: 10.1111/nmo.13275. [Epub ahead of print] PubMed PMID: 29278278.

↑ PAGE TOP